Science diplomacy

Status / emerging findings

• Political leadership failures—notably the Fleming Fund closure under Theresa May—have dismantled years of trusted relationships with countries critical to UK biosecurity (Nigeria, Indonesia, Pakistan), representing both a diplomatic and security loss.
• UK universities lack adequate cyber-security infrastructure to defend against credential-based attacks and foreign investment exploitation, yet academics are tasked with vetting risky collaborations without access to national security intelligence.
• MI5's April 2024 security warnings to researchers are already outdated; no systematic mechanism exists for regular, targeted briefings as technology and threat vectors evolve rapidly.
• Civil service silos between DHSC, DSIT, and the Office for Life Sciences prevent integration of science innovation with commercial opportunity and global health soft power.
• The locus of dual-use R&D has shifted eastward and from military to private sector (e.g. Samsung outspends UK military labs), requiring fundamentally new deterrence and policy approaches.

Why it matters

The UK's scientific reputation is a major economic and security asset, but political negligence and institutional fragmentation are eroding it while hostile states systematically target UK research; the committee is exposing how poor coordination between science, health, and security policy weakens both soft power and national resilience.

Tone arc

Opened procedural (examining dual-use threats and institutional vulnerabilities), sharpened into critique of political leadership and structural failures—the second session pivoted from security mechanics to the strategic abandonment of global health leadership as the primary risk.

Key witnesses

Lord O'Neill of Gatley, Professor Dame Jenny Harries, Dr Pia Hüsch (RUSI), James Black (RAND Europe), MI5 (referenced, not directly testified)